Malignant melanoma is an aggressive, therapy-resistant malignancy of melanocytes. The
incidence of melanoma has been steadily increasing worldwide, resulting in an increasing …

Primary vitreoretinal lymphoma (PVRL), also known as primary intraocular lymphoma, is a
rare malignancy typically classified as a diffuse large B‐cell lymphoma and most frequently …

Mutations in the gene BEST1 are causally associated with as many as five clinically distinct
retinal degenerative diseases, which are collectively referred to as the “bestrophinopathies”. …

PURPOSE: To describe the pharmacokinetics of 1.25 mg of intravitreal bevacizumab (Avastin).
DESIGN: Experimental animal study. PARTICIPANTS: Twenty Dutch-belted rabbits. …

PURPOSE: To describe the pharmacokinetics of 0.5 mg of intravitreal ranibizumab (Lucentis)
and to compare it with that of 1.25 mg of intravitreal bevacizumab (Avastin), using the same …

PURPOSE: To determine the incidence of central serous chorioretinopathy (CSC) in Olmsted
County, Minnesota from 1980 to 2002, determine the associated risk factors for CSC based …

Background: Primary intraocular lymphoma (PIOL) is an uncommon subset of primary central
nervous system lymphoma. Because it is rare and difficult to diagnose, the natural history …

The antibiotic regimens recommended for empiric use in posttraumatic endophthalmitis are
based on data collected from medical centers in large metropolitan areas. In rural areas, …

Purpose: To identify the ocular complications and to statistically evaluate the possible
association of pars planitis with multiple sclerosis (MS) in a homogeneous population of pars …

Purpose To assess the intraocular pressure (IOP) changes, within the first 30 min after intravitreal
injection of 0.1 ml (4 mg) triamcinolone, 0.09 ml (0.3 mg) pegaptanib, and 0.05 ml (1.25 …